Evaluation of Predictive Visual Analog Scale (VAS) for Determining the Ingesta of Patients Carrying a Digestive Cancer

Completed

• Conditions: Digestive System Neoplasms

• Registration Number: NCT02781532
• Lead Sponsor: Centre Hospitalier Universitaire de Nice

Brief Summary

The main objective of our study is to determine if the evaluation of ingesta of cancer patients by VAS (on the day of hospitalization) is able to predict the actual ingesta of patients during hospitalization (for patients malnourished, at risk of malnutrition or risk free).

Detailed Description

Not available

Study Timeline

• Study Start: 2014-04
• Primary Completion: 2015-01
• Study Completion: 2015-01
• Status Verified: 2016-05
• Study First Submitted: 2016-05-20
• Study First Submitted QC: 2016-05-23
• Last Update Submitted: 2016-05-23
• Study First Posted: 2016-05-24
• Last Update Posted: 2016-05-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients aged over 18 years
• Admitted to hospital for systemic therapy of gastrointestinal cancer
• Signature of the non-opposition.

Exclusion Criteria

• Patients who because of their affection will fasted more than 12:00 during the three days preceding hospitalization.
• Artificial nutrition Patients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of ingesta	3 days	Evaluation of ingesta will be done using SAV scale.

Trial Locations

Locations (1)

CHU de Nice; 🇫🇷 France, France